CD27 Gene Lymphoproliferative Syndrome Type 2 Genetic Test
At DNA Labs UAE, we offer the CD27 Gene Lymphoproliferative Syndrome Type 2 Genetic Test to diagnose and understand this rare genetic disorder. This test is crucial for individuals with an impaired immune system and increased susceptibility to infections.
Test Details
The CD27 gene lymphoproliferative syndrome type 2 is caused by mutations in the CD27 gene, which is responsible for the development and functioning of immune cells. Our Next-Generation Sequencing (NGS) technology allows us to analyze and sequence the entire CD27 gene, identifying any mutations or genetic variations that may be responsible for the syndrome.
Test Components and Price
The CD27 Gene Lymphoproliferative Syndrome Type 2 Genetic Test is priced at 4400.0 AED. The test requires a blood or extracted DNA sample, or even one drop of blood on an FTA Card.
Report Delivery and Method
After the sample is collected, the report will be delivered within 3 to 4 weeks. Our NGS technology ensures accurate and efficient analysis of the CD27 gene.
Test Type and Doctor
The CD27 Gene Lymphoproliferative Syndrome Type 2 Genetic Test falls under the categories of Osteology, Dermatology, and Immunology Disorders. It is recommended to consult with a dermatologist for this test.
Test Department
Our Genetics department handles the CD27 Gene Lymphoproliferative Syndrome Type 2 Genetic Test.
Pre Test Information
Prior to the test, it is important to provide the clinical history of the patient. A genetic counseling session will be conducted to draw a pedigree chart of family members affected by the syndrome and to discuss the implications of the test results.
NGS Genetic Testing Process
NGS genetic testing involves collecting a blood or saliva sample from the patient and extracting the DNA. The DNA is then sequenced using advanced technology that can analyze millions of DNA fragments simultaneously. The sequencing data is compared to a reference genome to identify any variations or mutations in the CD27 gene.
Importance of the Test
The results of the CD27 Gene Lymphoproliferative Syndrome Type 2 Genetic Test can provide valuable information for diagnosis, prognosis, and treatment. It helps determine the specific genetic mutation causing the disorder and guides appropriate management strategies, such as targeted therapies or bone marrow transplantation.
Ordering and Genetic Counseling
Please note that NGS genetic testing is typically performed in specialized laboratories and requires a healthcare professional’s order. Genetic counseling is often recommended before and after the test to discuss the implications of the results and provide support to the patient and their family.
| Test Name | CD27 Gene Lymphoproliferative syndrome type 2 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CD27 Gene Lymphoproliferative syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CD27 Gene Lymphoproliferative syndrome type 2 NGS Genetic DNA Test gene CD27 |
| Test Details | CD27 gene lymphoproliferative syndrome type 2 is a rare genetic disorder characterized by an impaired immune system and increased susceptibility to infections. It is caused by mutations in the CD27 gene, which plays a crucial role in the development and functioning of immune cells. NGS (Next-Generation Sequencing) genetic testing is a powerful tool used to analyze and sequence the entire CD27 gene. This test can identify any mutations or genetic variations in the CD27 gene that may be responsible for lymphoproliferative syndrome type 2. NGS genetic testing involves collecting a blood or saliva sample from the patient and extracting the DNA. The DNA is then sequenced using advanced technology that can analyze millions of DNA fragments simultaneously. The sequencing data is compared to a reference genome to identify any variations or mutations in the CD27 gene. The results of the NGS genetic test can provide valuable information for diagnosis, prognosis, and treatment of lymphoproliferative syndrome type 2. It can help determine the specific genetic mutation causing the disorder and guide appropriate management strategies, such as targeted therapies or bone marrow transplantation. It is important to note that NGS genetic testing is typically performed in specialized laboratories and requires a healthcare professional’s order. Genetic counseling is often recommended before and after the test to discuss the implications of the results and provide support to the patient and their family. |
